During the past decade, Lyon University Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lyon University Hospital" #1 sponsor was "Nantes University Hospital" with 9 trials, followed by "University Hospital, Grenoble" with 8 trials sponsored, "University Hospital, Toulouse" with 5 trials sponsored, "University Hospital, Bordeaux" with 4 trials sponsored and "Centre Hospitalier Universitaire de Nice" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyon University Hospital" #1 collaborator was "Ministry of Health, France" with 4 trials as a collaborator, "Hospices Civils de Lyon" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Alfediam" with 1 trials as a collaborator and "Centre Hospitalier de Cadillac, France" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Lyon University Hospital" are "Alzheimer's Disease" (2 trials), "Mitral Valve Regurgitation" (2 trials), "Multiple Sclerosis" (2 trials), "Type 1 Diabetes Mellitus" (2 trials) and "ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2" (1 trials). Many other conditions were trialed in "Lyon University Hospital" in a lesser frequency.

Most popular intervention types in "Lyon University Hospital" are "Other" (11 trials), "Procedure" (11 trials), "Device" (9 trials), "Drug" (8 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "human pancreatic islet transplantation" (2 trials), "Auto-injector pen, mepolizumab 100 mg/month" (1 trials), "BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)" (1 trials), "Biological mesh" (1 trials) and "CMS group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lyon University Hospital" are 43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lyon University Hospital". 2 are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Lyon University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lyon University Hospital, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".